DJIA 16,614.81 215.14 1.31%
NASDAQ 4,419.48 103.40 2.40%
S&P 500 1,941.28 37.27 1.96%
market minute promo

Synageva BioPharma (NASDAQ: GEVA)

73.14 -0.96 (-1.30%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GEVA $73.14 -1.30%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $75.14
Previous Close $74.10
Daily Range $71.46 - $75.14
52-Week Range $44.54 - $119.42
Market Cap $2.4B
P/E Ratio -15.63
Dividend (Yield) $0.00 (0.0%)
Volume 246,812
Average Daily Volume 290,710
Current FY EPS -$6.19

Sector

Healthcare

Industry

Drugs

Synageva BioPharma (GEVA) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of a new class of antiviral drug treatments called fusion inhibitors. Website: http://www.synageva.com/

News & Commentary Rss Feed

5 of Last Week's Biggest Losers

These five stocks suffered double-digit percentage declines last week.

Synageva BioPharma (GEVA) Shows Strength: Stock Up 7.4% - Tale of the Tape

3 Big-Volume Stocks to Trade for Breakouts

Synageva Slips on Wider-than-Expected Q2 Loss - Analyst Blog

Thursday's ETF Movers: BSCF, XBI

Sector Update: Health Care

Sector Update: Health Care Stocks Following Broader Markets Highers; GlycoMimetics Jumps More Than 1

Sector Update: Health Care Stocks Following Broader Markets Highers; GlycoMimetics Jumps More Than 10% After Naming Cancer-Specialist to Board

3 Stocks Crushed by the Market This Week

No pops and sizzles for these stocks. Just drops and fizzles.

Synageva Shares Tumble Amid Positive Phase 3 Data, A Director's 75% Gain & Analyst Concerns

Synageva's Sebelipase Alfa Meets Primary Endpoint in ARISE - Analyst Blog

See More GEVA News...

GEVA's Top Competitors

GEVA $73.14 (-1.30%)
Current stock: GEVA
AMGN $144.09 (4.79%)
Current stock: AMGN
GILD $106.67 (4.36%)
Current stock: GILD
BIIB $326.77 (4.93%)
Current stock: BIIB